1-Fluoro-2-nitro-4-azidobenzene → (1R,2R,3S,4R,5S)-4-(2-Chloro-6-(3-(5-(1-(4-fluoro-3-nitrophenyl)-1H-1,2,3-triazol-4-yl)pent-1-ynyl)benzylamino)-9H-purin-9-yl)-bicyclo[3.1.0]hexane-2,3-diol

HRID 1896228Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1896228
[F:1][C:2]1[CH:7]=[CH:6][C:5]([N:8]=[N+:9]=[N-:10])=[CH:4][C:3]=1[N+:11]([O-:13])=[O:12].CCCC[Sn](OC(C)=O)(CCCC)CCCC.[Cl:31][C:32]1[N:40]=[C:39]2[C:35]([N:36]=[CH:37][N:38]2[C@@H:41]2[C@@H:46]3[C@@H:44]([CH2:45]3)[C@@H:43]([OH:47])[C@H:42]2[OH:48])=[C:34]([NH:49][CH2:50][C:51]2[CH:56]=[CH:55][CH:54]=[C:53]([C:57]#[C:58][CH2:59][CH2:60][CH2:61][C:62]#[CH:63])[CH:52]=2)[N:33]=1.O=C1O[C@H]([C@H](CO)O)C([O-])=C1O.[Na+]>C(Cl)Cl.C(O)(C)(C)C.S([O-])([O-])(=O)=O.[Cu+2].O>[Cl:31][C:32]1[N:40]=[C:39]2[C:35]([N:36]=[CH:37][N:38]2[C@@H:41]2[C@@H:46]3[C@@H:44]([CH2:45]3)[C@@H:43]([OH:47])[C@H:42]2[OH:48])=[C:34]([NH:49][CH2:50][C:51]2[CH:56]=[CH:55][CH:54]=[C:53]([C:57]#[C:58][CH2:59][CH2:60][CH2:61][C:62]3[N:10]=[N:9][N:8]([C:5]4[CH:6]=[CH:7][C:2]([F:1])=[C:3]([N+:11]([O-:13])=[O:12])[CH:4]=4)[CH:63]=3)[CH:52]=2)[N:33]=1

Komponenten

8

Edukt 4

HCID 931211-Fluoro-2-nitro-4-azidobenzeneHCID 16682741Tributyltin acetateHCID 23667548Sodium AscorbateHCID 86672495(1R,2R,3S,4R,5S)-4-(2-Chloro-6-(3-(hepta-1,6-diynyl)benzylamino)-9H-purin-9-yl) bicyclo[3.1.0]hexane-2,3-diol

Produkt 1

HCID 86672494(1R,2R,3S,4R,5S)-4-(2-Chloro-6-(3-(5-(1-(4-fluoro-3-nitrophenyl)-1H-1,2,3-triazol-4-yl)pent-1-ynyl)benzylamino)-9H-purin-9-yl)-bicyclo[3.1.0]hexane-2,3-diolAusbeute 91 %

Reagenzien, Katalysatoren, Lösungsmittel 3

HCID 24462Copper SulfateKatalysatorHCID 962WaterLösungsmittelHCID 18914702t-Butanol dichloromethaneLösungsmittel

Versuchsvorschrift

4-Fluoro-3-nitro-phenylazide (7.5 mg, 0.041 mmol) and TBTA (1 mg, 0.001 mmol) were added to a solution of compound 211 (13.5 mg, 0.029 mmol) in CH2Cl2-t-butanol (0.6 mL)-water (0.6 mL) at room temperature. Freshly prepared 1M solution of sodium ascorbate (29.2 μL) followed by 7.5% solution of copper sulfate (48 μL, 0.015 mmol) was also added into the reaction mixture stirred at room temperature overnight. Solvent was evaporated, and the residue was purified on flash silica gel column chromatography (CH2Cl2:MeOH=45:1) to give compound 214 (17 mg, 91%) as a syrup. 1H NMR (CD3OD, 400 MHz) δ 861-8.59 (m, 1H), 8.49 (s, 1H), 8.23-8.19 (m, 1H), 8.14 (s, 1H), 7.65 (t, J=9.2 Hz, 1H), 7.39 (s, 1H), 7.33-7.24 (m, 3H), 4.79 (s, 1H), 4.72-4.70 (m, 3H), 3.90 (d, J=6.4 Hz, 1H), 2.99 (t, J=7.6 Hz, 2H), 2.53 (t, J=6.8 Hz, 2H), 2.08-1.96 (m, 3H), 1.69-1.65 (m, 1H), 1.33-1.30 (m, 1H), 0.79-0.75 (m, 1H). HRMS calculated for C31H28ClFN9O4 (M+H)+: 644.1937. Found 644.1962.

Aufarbeitung

  1. additionwas also added into the reaction mixture
  2. customSolvent was evaporated
  3. customthe residue was purified on flash silica gel column chromatography (CH2Cl2:MeOH=45:1)

Quellen und Nachweise

ORD-Eintrag
ord-d8d1652af8344f9396dd9d39766493eb
Quelldatensatz
uspto-grants-2013_08
Patentnummer
US08518957B2

Notizen zur Reaktion

Wird geladen…